Lucy A. Young
Impact in
-
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
-
- DNA Repair Mechanisms
- CRISPR and Genetic Engineering
- Cell death mechanisms and regulation
- Cancer therapeutics and mechanisms
Papers in
-
- DNA Repair Mechanisms 6
- CRISPR and Genetic Engineering 2
- Protein Degradation and Inhibitors 1
- Oncology 4
- PARP inhibition in cancer therapy 3
- Co-authors
- Alan Lau (4 shared papers)Zena Wilson (5 shared papers)Gemma N. Jones (2 shared papers)Antonio Ramos‐Montoya (2 shared papers)Christophe D. Chabbert (2 shared papers)Paul W.G. Wijnhoven (2 shared papers)Jonathan Stott (2 shared papers)Emma Dean (1 shared paper)
- Journals
- Cancer Research (4 papers)OncoImmunology (1 paper)Molecular Cancer Therapeutics (1 paper)British Journal of Cancer (1 paper)Oncogene (1 paper)
- Partner nations
- United KingdomUnited StatesSingapore
In The Last Decade
Lucy A. Young
9 papers receiving 274 citations
Peers
Comparison fields: 5 of 39
- Oncology 165
- Molecular Biology 182
- Immunology 38
- Cancer Research 19
- Cell Biology 20
Countries citing papers authored by Lucy A. Young
This map shows the geographic impact of Lucy A. Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucy A. Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucy A. Young more than expected).
Fields of papers citing papers by Lucy A. Young
This network shows the impact of papers produced by Lucy A. Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucy A. Young. The network helps show where Lucy A. Young may publish in the future.
Co-authors
The 25 scholars most cited alongside Lucy A. Young, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 131 | |
| 2 | 2019 | 55 | |
| 3 | 2018 | 30 | |
| 4 | 2022 | 26 | |
| 5 | 2019 | 16 | |
| 6 | 2018 | 6 | |
| 7 | Paclitaxel decreases the accumulation of gemcitabine and its metabolites in human leukemia cells and primary cell cultures. | 2006 | 6 |
| 8 | 2018 | 3 | |
| 9 | 2017 | 2 |
About Lucy A. Young
Lucy A. Young is a scholar working on Molecular Biology, Oncology, Genetics, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 9 papers that have together received 275 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (6 papers), PARP inhibition in cancer therapy (3 papers), CRISPR and Genetic Engineering (2 papers), Chronic Lymphocytic Leukemia Research (1 paper), Genetics and Neurodevelopmental Disorders (1 paper), Radiation Therapy and Dosimetry (1 paper), interferon and immune responses (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Oncology (165 citations), Molecular Biology (182 citations), Immunology (38 citations), Cancer Research (19 citations) and Cell Biology (20 citations). Lucy A. Young has collaborated with scholars based in United Kingdom, United States and Singapore. Frequent co-authors include Alan Lau, Zena Wilson, Gemma N. Jones, Antonio Ramos‐Montoya, Christophe D. Chabbert, Paul W.G. Wijnhoven, Jonathan Stott, Emma Dean, Giuditta Illuzzi and Neil H. James. Their work appears in journals such as Cancer Research, OncoImmunology, Molecular Cancer Therapeutics, British Journal of Cancer and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.